register

News & Trends - Pharmaceuticals

TGA publishes vaccine safety monitoring plan

Health Industry Hub | February 19, 2021 |

Pharma News: The Therapeutic Goods Administration (TGA) has published a five-point plan detailing the enhanced measures it will put in place to ensure the timely identification and mitigation of safety issues during the roll out of COVID-19 vaccines.

The publication of the plan follows the recent provisional approvals of Pfizer/BioNTech and AstraZeneca/University of Oxford vaccines, and the start of a national vaccination strategy that is initially targeting around 700,000 people, including quarantine and border workers and the residents and staff at aged and disability care facilities.

The agency aims to “strengthen the existing vaccine vigilance system for early detection and investigation of suspected side effects,” thereby enabling it to manage emerging safety issues and maintain public confidence.

Specifically, TGA is putting into place an enhanced adverse event reporting process to ensure the timely collection and management of reports; forms will be particularised for each vaccine and will be sharable between its staff and regional officials.

The agency also seeks to enhance safety signal detection and investigation by ensuring it has the capacity to perform timely reviews of adverse event reports and the ability to collaborate in real time with AusVaxSafety, the national vaccine safety system. Upon identification of a safety concern, TGA will “use legislative provisions available to achieve effective and timely regulatory action” that may help to address or reduce the emerging risk.

TGA also will ensure information quickly reaches consumers, health professionals and sponsors and will proactively monitor media reports to proactively identify public concerns about vaccine safety.

To achieve those goals, TGA plans to collaborate with state and federal governments and experts in Australia on the consolidation of “timely information sharing, communication and collaboration with national stakeholders on COVID-19 vaccine safety,” as well as with officials and regulators overseas.

See details of TGA’s Monitoring Plan.


News & Trends - MedTech & Diagnostics

Government's claim of progress in genomics falls flat while it fails to uphold the fundamental rights of Aussies

Government’s claim of progress in genomics falls flat while it fails to uphold the fundamental rights of Aussies

Health Industry Hub | February 7, 2025 |

The government has unveiled Cancer Australia’s National Framework for Genomics in Cancer Control, a strategic plan designed to guide healthcare […]

More


News & Trends - Pharmaceuticals

Healthcare sector’s political donations: What to expect ahead of the federal election

Healthcare sector’s political donations: What to expect ahead of the federal election

Health Industry Hub | February 7, 2025 |

Ahead of the upcoming federal election, attention turns to the financial contributions to major political parties. The Australian Electoral Commission’s […]

More


News & Trends - Pharmaceuticals

'Underinvestment in gynae cancer has left critical gaps,' says ANZGOG Chair

‘Underinvestment in gynae cancer has left critical gaps,’ says ANZGOG Chair

Health Industry Hub | February 7, 2025 |

Ovarian cancer is the deadliest women’s cancer, with the latest statistics revealing a five-year survival rate of just 49%. Alarmingly, […]

More


News & Trends - MedTech & Diagnostics

Labor's one-off funding a band aid for public hospitals while private sector left in limbo

Labor’s one-off funding a band aid for public hospitals while private sector left in limbo

Health Industry Hub | February 6, 2025 |

The Federal Government has committed a one-off funding boost of $1.7 billion to public hospitals under a one-year extension to […]

More


This content is copyright protected. Please subscribe to gain access.